A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy.
Zhentang LaoLing-Wen DingQiao-Yang SunLi JiaBenedict YanAlvin Yu-Jin NgSharah Mae CapinpinRenwei WangYing LiWee-Joo ChngH Phillip KoefflerWoon-Puay KohWoon Puay KohHenry YangYeow Tee GohNicholas Francis GrigoropoulosPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
The epigenetic changes may be acquired independently and prior to somatic mutations that relevant for AML/MDS development. The association between methylation changes and the risk of pre-AML/MDS in these individuals was considerably stronger than somatic mutations, suggesting that methylation changes could be used as biomarkers for pre- AML/MDS screening.